Search research articles
Contact Us
Filters
Showing results (91-100 of 126) with videos related to
Page
of 13
Sort By:
British Journal of Haematology
|
July 15, 2009
Detection of gene copy number aberrations in mantle cell lymphoma by a single quantitative multiplex PCR assay: clinicopathological relevance and prognosis value
Fabrice Jardin, Jean-Michel Picquenot, Françoise Parmentier, et al.
Haematologica
|
March 10, 2015
Somatic mutations of cell-free circulating DNA detected by next-generation sequencing reflect the genetic changes in both germinal center B-cell-like and activated B-cell-like diffuse large B-cell lymphomas at the time of diagnosis
Elodie Bohers, Pierre Julien Viailly, Sydney Dubois, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
October 26, 2017
SAR110894, a potent histamine H3-receptor antagonist, displays disease-modifying activity in a transgenic mouse model of tauopathy
Philippe Delay-Goyet, Véronique Blanchard, Nathalie Schussler, et al.
Leukemia & Lymphoma
|
August 3, 2018
Somatic mutations of cell-free circulating DNA detected by targeted next-generation sequencing and digital droplet PCR in classical Hodgkin lymphoma
Lucile Bessi, Pierre-Julien Viailly, Elodie Bohers, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 2, 2010
Design of potent and selective GSK3beta inhibitors with acceptable safety profile and pharmacokinetics
Dominique Lesuisse, Gilles Tiraboschi, Alain Krick, et al.
The Journal of Urology
|
July 27, 2014
Prosbiotate: a multicenter, prospective analysis of infectious complications after prostate biopsy
Franck Bruyère, Sandra Malavaud, Philippe Bertrand, et al.
American Journal of Hematology
|
October 14, 2016
Oncogenic events rather than antigen selection pressure may be the main driving forces for relapse in diffuse large B-cell lymphomas
David Rizzo, Pierre-Julien Viailly, Sylvain Mareschal, et al.
Oncotarget
|
March 13, 2015
Immunohistochemical and genomic profiles of diffuse large B-cell lymphomas: implications for targeted EZH2 inhibitor therapy?
Sydney Dubois, Sylvain Mareschal, Jean-Michel Picquenot, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
June 6, 2021
Left ventricular function recovery after ST-elevation myocardial infarction: correlates and outcomes
Jeroen Dauw, Pieter Martens, Sébastien Deferm, et al.
Leukemia Research
|
April 24, 2016
HACE1 is a putative tumor suppressor gene in B-cell lymphomagenesis and is down-regulated by both deletion and epigenetic alterations
Abdelilah Bouzelfen, Marion Alcantara, Hafid Kora, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 126) with videos related to
Sort By:
Page
of 13
British Journal of Haematology
|
July 15, 2009
Detection of gene copy number aberrations in mantle cell lymphoma by a single quantitative multiplex PCR assay: clinicopathological relevance and prognosis value
Fabrice Jardin, Jean-Michel Picquenot, Françoise Parmentier, et al.
Haematologica
|
March 10, 2015
Somatic mutations of cell-free circulating DNA detected by next-generation sequencing reflect the genetic changes in both germinal center B-cell-like and activated B-cell-like diffuse large B-cell lymphomas at the time of diagnosis
Elodie Bohers, Pierre Julien Viailly, Sydney Dubois, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
October 26, 2017
SAR110894, a potent histamine H3-receptor antagonist, displays disease-modifying activity in a transgenic mouse model of tauopathy
Philippe Delay-Goyet, Véronique Blanchard, Nathalie Schussler, et al.
Leukemia & Lymphoma
|
August 3, 2018
Somatic mutations of cell-free circulating DNA detected by targeted next-generation sequencing and digital droplet PCR in classical Hodgkin lymphoma
Lucile Bessi, Pierre-Julien Viailly, Elodie Bohers, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 2, 2010
Design of potent and selective GSK3beta inhibitors with acceptable safety profile and pharmacokinetics
Dominique Lesuisse, Gilles Tiraboschi, Alain Krick, et al.
The Journal of Urology
|
July 27, 2014
Prosbiotate: a multicenter, prospective analysis of infectious complications after prostate biopsy
Franck Bruyère, Sandra Malavaud, Philippe Bertrand, et al.
American Journal of Hematology
|
October 14, 2016
Oncogenic events rather than antigen selection pressure may be the main driving forces for relapse in diffuse large B-cell lymphomas
David Rizzo, Pierre-Julien Viailly, Sylvain Mareschal, et al.
Oncotarget
|
March 13, 2015
Immunohistochemical and genomic profiles of diffuse large B-cell lymphomas: implications for targeted EZH2 inhibitor therapy?
Sydney Dubois, Sylvain Mareschal, Jean-Michel Picquenot, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
June 6, 2021
Left ventricular function recovery after ST-elevation myocardial infarction: correlates and outcomes
Jeroen Dauw, Pieter Martens, Sébastien Deferm, et al.
Leukemia Research
|
April 24, 2016
HACE1 is a putative tumor suppressor gene in B-cell lymphomagenesis and is down-regulated by both deletion and epigenetic alterations
Abdelilah Bouzelfen, Marion Alcantara, Hafid Kora, et al.
Page
of 13